Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
T Cell
65%
COVID-19
56%
Immune Response
34%
Spike
30%
B Cell
26%
Humoral Immunity
24%
Immunosuppression
23%
Immunogenicity
23%
Methotrexate
23%
Immunology
23%
Immunotherapy
23%
Adoptive Immunity
22%
Virus
20%
Biological Product
14%
Gene Expression Assay
11%
Intravenous Immunoglobulin
11%
Seroconversion
10%
Antibody Response
10%
Antigen Specificity
10%
Cytokine
9%
Peptides
9%
Neutralizing Antibody
8%
Regulatory T Cell
8%
Antibody Titer
7%
Wild Type
5%
Population Research
5%
TNF Inhibitor
5%
Interleukin 17
5%
Interleukin 23
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
52%
COVID-19 Vaccine
47%
Hematologic Malignancy
47%
Virus
31%
Humoral Immunity
24%
Cohort Analysis
23%
Immunosuppressive Treatment
23%
Methotrexate
23%
Immunogenicity
23%
T-Cell Response
19%
Cellular Immunity
18%
T Cell
15%
Cancer Therapy
15%
Cancer Types
15%
Cancer Treatment
15%
Myelodysplastic Syndrome
15%
Malignant Neoplasm
15%
COVID-19 Vaccination
15%
Antigen Specificity
15%
Seroconversion
15%
Biological Product
14%
Psoriasis
14%
Immune Response
13%
Neutralizing Antibody
8%
Patient Population
7%
Immunocompromised Patient
7%
Neutralization
7%
Antibody Response
5%
TNF Inhibitor
5%
Population Research
5%
Interleukin 17
5%
Interleukin 23
5%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
70%
T Cell
39%
B Cell
26%
Spike
18%
Cellular Immunity
15%
Humoral Immunity
10%
Regulatory T Cell
8%
Cytokine
6%
Seroconversion
5%
Antigen Specificity
5%
